Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.
Eriksson M, Eklund M, Borgquist S, Hellgren R, Margolin S, Thoren L, Rosendahl A, Lång K, Tapia J, Bäcklund M, Discacciati A, Crippa A, Gabrielson M, Hammarström M, Wengström Y, Czene K, Hall P. Eriksson M, et al. Among authors: wengstrom y. J Clin Oncol. 2021 Jun 10;39(17):1899-1908. doi: 10.1200/JCO.20.02598. Epub 2021 Mar 18. J Clin Oncol. 2021. PMID: 33734864 Free PMC article. Clinical Trial.
Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial.
Mijwel S, Backman M, Bolam KA, Jervaeus A, Sundberg CJ, Margolin S, Browall M, Rundqvist H, Wengström Y. Mijwel S, et al. Among authors: wengstrom y. Breast Cancer Res Treat. 2018 Feb;168(1):79-93. doi: 10.1007/s10549-017-4571-3. Epub 2017 Nov 14. Breast Cancer Res Treat. 2018. PMID: 29139007 Free PMC article. Clinical Trial.
Sense of coherence and risk of breast cancer.
Hu K, Eriksson M, Wengström Y, Czene K, Hall P, Fang F. Hu K, et al. Among authors: wengstrom y. Elife. 2020 Nov 23;9:e61469. doi: 10.7554/eLife.61469. Elife. 2020. PMID: 33226344 Free PMC article.
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial.
He W, Eriksson M, Eliasson E, Grassmann F, Bäcklund M, Gabrielson M, Hammarström M, Margolin S, Thorén L, Wengström Y, Borgquist S, Hall P, Czene K. He W, et al. Among authors: wengstrom y. Ann Oncol. 2021 Oct;32(10):1286-1293. doi: 10.1016/j.annonc.2021.07.005. Epub 2021 Jul 18. Ann Oncol. 2021. PMID: 34284099 Free article. Clinical Trial.
Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
Forsberg A, Westerberg M, Metcalfe C, Steele R, Blom J, Engstrand L, Fritzell K, Hellström M, Levin LÅ, Löwbeer C, Pischel A, Strömberg U, Törnberg S, Wengström Y, Ekbom A, Holmberg L, Hultcrantz R; SCREESCO investigators. Forsberg A, et al. Among authors: wengstrom y. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):513-521. doi: 10.1016/S2468-1253(21)00473-8. Epub 2022 Mar 14. Lancet Gastroenterol Hepatol. 2022. PMID: 35298893 Clinical Trial.
Time to Mammographic Density Decrease After Exposure to Tamoxifen.
Bäcklund M, Eriksson M, Hammarström M, Thoren L, Bergqvist J, Margolin S, Hellgren R, Wengström Y, Gabrielson M, Czene K, Hall P. Bäcklund M, et al. Among authors: wengstrom y. Oncologist. 2022 Jul 5;27(7):e601-e603. doi: 10.1093/oncolo/oyac104. Oncologist. 2022. PMID: 35605013 Free PMC article. Clinical Trial.
172 results